Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

Jesus Esquivel, Dominique Elias, Dario Baratti, Shigeki Kusamura, Marcello Deraco

Research output: Contribution to journalArticle

Abstract

Medical management with combinations of cytotoxic chemotherapy, and/or biological agents, has resulted in an unprecedented median survival >20 months in patients with Stage IV colorectal cancer. The management of disease limited to the peritoneal cavity has been controversial and at the present time, there is no published data that outlines the impact of these new therapeutic regimens when given to patients with colorectal cancer with metastatic disease confined to the peritoneum. Over the last 5 years, an increasing number of international treatment centers have published their prospective results using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of peritoneal surface malignancies of colorectal origin and have shown that good long-term results can be achieved with a complete cytoreduction and HIPEC. However, most of the surgical data comes from Phase II studies from single institutions and there is a wide range on inclusion/exclusion criteria, drugs, temperatures and methods of delivering the heated chemotherapy. This manuscript will analyze and discuss the results of a group of health care providers trying to achieve a consensus statement in the management of this group of patients.

Original languageEnglish
Pages (from-to)263-267
Number of pages5
JournalJournal of Surgical Oncology
Volume98
Issue number4
DOIs
Publication statusPublished - Sep 15 2008

Keywords

  • Cytoreductive surgery
  • Intraperitoneal chemotherapy
  • Peritoneal carcinomatosis

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination'. Together they form a unique fingerprint.

  • Cite this